JUNS
Jupiter Neurosciences, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Last price
6.12
▲ 0.95 (18.38%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
5.27
Prev close
5.17
Day high
11.20
Day low
5.50
Volume
52.20M
Market cap
$4.77M
P/E (TTM)
—
52W range
4.56 – 138.00
Day trading desk
Gap from prior close
+1.93%
Prior close 5.17
VWAP
8.41
-27.20% from price
Relative volume
53.18×
Unusually busy
Session range
124.00%
5.00 – 11.20
Position in range
18%
Near session low
ATR (14D)
1.35
22.00% of price
Prior day high
5.23
PDH
Prior day low
4.80
PDL
Bid / ask spread
—
Quote not published
Session volume
51.98M
Avg 977.49K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+18.32%
+19.7%
1M
+3,952.29%
+3,948.6%
3M
+2,187.82%
+2,184.7%
6M
+1,092.31%
+1,081.2%
YTD
+507.84%
+495.6%
1Y
+287.50%
+267.5%
3Y
—
-74.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on JUNS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
243.74K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Mar 2, 26 | HAYWARD MARSHALL A PH.D. Officer and Director |
CONVERSION | 1.01M | $2.25K | Direct |
| Jul 1, 25 | ROSEN CHRISTER Chief Executive Officer |
BUY | 3.60K | $3.67K | Direct |
| Jul 1, 25 | SILVA ALISON D President |
BUY | 750 | $772 | Direct |
| Jun 30, 25 | ROSEN CHRISTER Chief Executive Officer |
BUY | 7.82K | $7.99K | Direct |
| Jun 30, 25 | SILVA ALISON D President |
BUY | 1.80K | $1.85K | Direct |
| Jun 2, 25 | WEIS HOLGER Director |
— | 85.80K | — | Direct |
| Jun 2, 25 | KAMPF JULIE B. Director |
— | 82.88K | — | Direct |
| Jun 2, 25 | ELMASRI SALEEM C Chief Financial Officer |
— | 66.29K | — | Direct |
| Jun 2, 25 | HEMMERLY NICHOLAS H Director |
— | 95.55K | — | Direct |
| Jun 2, 25 | ROSEN CHRISTER Chief Executive Officer |
— | 973.47K | — | Direct |
| Jun 2, 25 | ROSEN ALEXANDER GUSTAF ERIK Officer |
— | 261.16K | — | Direct |
| Jun 2, 25 | SILVA ALISON D President |
— | 110.23K | — | Direct |
| Jan 22, 25 | WEIS HOLGER Director |
CONVERSION | 10.78K | $30.19K | Direct |
| Jan 22, 25 | BRADY ALLISON W Director |
CONVERSION | 21.75K | $60.90K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BRADY ALLISON W |
Director | 21.75K | Conversion of Exercise of derivative security |
ELMASRI SALEEM C |
Chief Financial Officer | 0 | Conversion of Exercise of derivative security |
HAYWARD MARSHALL A PH.D. |
Officer and Director | 3.00M | Conversion of Exercise of derivative security |
HEMMERLY NICHOLAS H |
Director | 95.55K | Conversion of Exercise of derivative security |
KAMPF JULIE B. |
Director | 82.88K | Conversion of Exercise of derivative security |
ROSEN ALEXANDER GUSTAF ERIK |
Officer | 617.41K | Conversion of Exercise of derivative security |
ROSEN CHRISTER |
Chief Executive Officer | 11.08M | Purchase |
SILVA ALISON D |
President | 112.78K | Purchase |
WEIS HOLGER |
Director | 96.58K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$4.77M
Enterprise value$5.00M
Revenue (TTM)$64.69K
Gross profit$-2.03M
EBITDA—
Net income$-9.20M
EPS (TTM)$-18.70
Free cash flow$-3.30M
Total cash$1.52M
Total debt$1.75M
Book value / share$-5.75
Shares outstanding770.08K
Float477.67K
Short % of float0.48%
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E103.33
PEG ratio—
Price / sales—
Price / book—
EV / revenue77.31
EV / EBITDA—
Gross margin0.00%
Operating margin-11313.45%
Profit margin0.00%
Return on equity-1888.70%
Return on assets-159.56%
Debt / equity—
Current ratio0.66
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $21.80K | $0 | $0 | $233.28K | — |
| Operating revenue | $21.80K | $0 | $0 | $233.28K | — |
| Cost of revenue | $4.23K | — | — | — | — |
| Gross profit | $17.57K | — | — | — | — |
| Research & development | $2.09M | $492.66K | $954.79K | $942.81K | +323.5% |
| Selling, general & admin | $6.84M | $2.60M | $2.92M | $2.72M | +163.2% |
| Total operating expense | $8.93M | $3.09M | $3.87M | $3.67M | +188.8% |
| Operating income | -$8.91M | -$3.09M | -$3.87M | -$3.43M | -188.2% |
| Net interest income | -$66.02K | -$242.81K | -$218.22K | -$740.24K | +72.8% |
| Pre-tax income | -$8.64M | -$2.44M | -$4.78M | -$4.96M | -254.4% |
| Net income | -$8.64M | -$2.44M | -$4.78M | -$4.96M | -254.4% |
| Net income to common | -$8.64M | -$2.44M | -$4.78M | -$4.96M | -254.4% |
| Basic EPS | -18.75 | -6.00 | -13.50 | -11.31 | -212.5% |
| Diluted EPS | -18.75 | -6.00 | -13.50 | -11.31 | -212.5% |
| EBIT | -$8.58M | -$2.19M | -$4.56M | -$4.22M | -291.5% |
| EBITDA | -$8.58M | -$2.19M | -$4.56M | -$4.22M | -291.5% |
| Basic shares | 461.71K | 383.77K | 352.07K | 438.35K | +20.3% |
| Diluted shares | 461.71K | 383.77K | 352.07K | 438.35K | +20.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.79M | $3.77M | $28.48K | $64.43K | — | +0.5% |
| Cash & short-term investments | $3.79M | $3.77M | $28.48K | $64.43K | — | +0.5% |
| Accounts receivable | $2.64K | $0 | — | — | — | — |
| Inventory | $159.79K | $0 | — | — | — | — |
| Total current assets | $4.82M | $4.65M | $28.74K | $69.66K | — | +3.8% |
| Property, plant & equipment | $23.21K | $69.64K | $116.07K | $162.50K | — | -66.7% |
| Total assets | $5.56M | $6.20M | $148.59K | $235.94K | — | -10.3% |
| Total current liabilities | $7.40M | $2.01M | $5.77M | $7.26M | — | +268.1% |
| Current debt | $5.30M | $146.43K | $2.02M | $1.73M | — | +3,518.1% |
| Long-term debt | — | — | $106.71K | — | — | — |
| Total debt | $5.32M | $217.76K | $2.25M | $1.90M | — | +2,342.7% |
| Total liabilities | $7.40M | $2.03M | $5.95M | $7.38M | — | +264.3% |
| Retained earnings | -$34.67M | -$26.02M | -$23.58M | -$18.80M | — | -33.2% |
| Shareholder equity | -$1.83M | $4.17M | -$5.80M | -$7.14M | — | -143.9% |
| Working capital | -$2.57M | $2.64M | -$5.74M | -$7.19M | — | -197.3% |
| Net tangible assets | -$1.83M | $4.17M | -$5.80M | -$7.14M | — | -143.9% |
| Shares issued | 459.29K | 441.38K | — | — | 441.32K | +4.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$8.64M | -$2.44M | -$4.78M | -$4.96M | -254.4% |
| Stock-based compensation | $2.42M | $1.84M | $1.20M | $817.25K | +31.4% |
| Change in working capital | $105.39K | -$2.57M | $2.35M | $1.55M | +104.1% |
| Operating cash flow | -$5.41M | -$3.91M | -$480.95K | -$1.25M | -38.4% |
| Financing cash flow | $5.43M | $7.65M | $445.00K | $982.33K | -29.0% |
| Free cash flow | -$5.41M | -$3.91M | -$480.95K | -$1.25M | -38.4% |
| End cash position | $3.79M | $3.77M | $28.48K | $64.43K | +0.5% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $18.65K | $21.80K | $0 | $0 | $0 | -14.4% |
| Operating revenue | $18.65K | $21.80K | $0 | $0 | $0 | -14.4% |
| Cost of revenue | $4.36K | — | — | — | $0 | — |
| Gross profit | $14.29K | — | — | — | $0 | — |
| Research & development | $411.05K | $43.68K | $816.70K | $759.45K | $466.75K | +841.0% |
| Selling, general & admin | $1.57M | $2.78M | $1.48M | $1.51M | $1.07M | -43.7% |
| Total operating expense | $1.98M | $2.83M | $2.30M | $2.26M | $1.54M | -30.0% |
| Operating income | -$1.96M | -$2.81M | -$2.30M | -$2.26M | -$1.54M | +30.1% |
| Net interest income | -$100.24K | -$96.09K | $9.02K | $11.91K | $9.14K | -4.3% |
| Pre-tax income | -$2.06M | -$2.58M | -$2.29M | -$2.25M | -$1.53M | +19.9% |
| Net income | -$2.06M | -$2.58M | -$2.29M | -$2.25M | -$1.53M | +19.9% |
| Net income to common | -$2.06M | -$2.58M | -$2.29M | -$2.25M | -$1.53M | +19.9% |
| Basic EPS | -4.50 | — | -5.25 | -5.25 | -3.75 | — |
| Diluted EPS | -4.50 | — | -5.25 | -5.25 | -3.75 | — |
| EBIT | -$1.94M | -$2.51M | -$2.29M | -$2.25M | -$1.53M | +22.7% |
| EBITDA | -$1.94M | -$2.51M | -$2.29M | -$2.25M | -$1.53M | +22.7% |
| Basic shares | 470.07K | — | 453.87K | 442.41K | 441.38K | — |
| Diluted shares | 470.07K | — | 453.87K | 442.41K | 441.38K | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.36M | $3.79M | $723.80K | $1.88M | $2.71M | — | -37.6% |
| Cash & short-term investments | $2.36M | $3.79M | $723.80K | $1.88M | $2.71M | — | -37.6% |
| Accounts receivable | $0 | $2.64K | — | — | — | $0 | -100.0% |
| Inventory | $148.07K | $159.79K | — | — | — | $0 | -7.3% |
| Total current assets | $3.41M | $4.82M | $1.63M | $2.82M | $3.61M | — | -29.3% |
| Property, plant & equipment | $11.61K | $23.21K | $34.82K | $46.65K | $58.03K | — | -50.0% |
| Total assets | $3.95M | $5.56M | $2.58M | $3.97M | $4.96M | — | -29.0% |
| Total current liabilities | $6.73M | $7.40M | $2.52M | $2.63M | $1.89M | — | -9.0% |
| Current debt | $4.82M | $5.30M | $146.43K | $146.43K | $146.43K | — | -8.9% |
| Total debt | $4.83M | $5.32M | $180.39K | $192.86K | $205.50K | — | -9.1% |
| Total liabilities | $6.73M | $7.40M | $2.52M | $2.63M | $1.90M | — | -9.0% |
| Retained earnings | -$36.73M | -$34.67M | -$32.09M | -$29.80M | -$27.55M | — | -5.9% |
| Shareholder equity | -$2.78M | -$1.83M | $57.42K | $1.34M | $3.06M | — | -51.9% |
| Working capital | -$3.32M | -$2.57M | -$886.48K | $191.15K | $1.72M | — | -29.2% |
| Net tangible assets | -$2.78M | -$1.83M | $57.42K | $1.34M | $3.06M | — | -51.9% |
| Shares issued | 483.75K | 459.29K | 457.26K | 464.44K | 441.38K | — | +5.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$2.06M | -$2.58M | -$2.29M | -$2.25M | -$1.53M | +19.9% |
| Stock-based compensation | $500.99K | $463.24K | $1.07M | $462.49K | $421.45K | +8.1% |
| Change in working capital | -$190.37K | -$390.06K | -$64.99K | $705.11K | -$144.67K | +51.2% |
| Operating cash flow | -$1.43M | -$2.37M | -$1.15M | -$828.22K | -$1.06M | +39.5% |
| Financing cash flow | $5.51K | $5.43M | $0 | $0 | $0 | -99.9% |
| Free cash flow | -$1.43M | -$2.37M | -$1.15M | -$828.22K | -$1.06M | +39.5% |
| End cash position | $2.36M | $3.79M | $723.80K | $1.88M | $2.71M | -37.6% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Sep 2025 | -6.00 | -5.25 | +12.5% |
| Jun 2025 | -5.25 | -5.25 | 0.0% |
| Mar 2025 | -2.25 | -3.75 | -66.7% |
| Dec 2024 | -1.50 | -3.75 | -150.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders31.65%
Held by institutions3.85%
Institutions holding13
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
5.23
+17.08% from price
SMA 20
3.52
+76.02% from price
SMA 50
2.29
+171.03% from price
SMA 100
1.31
+366.33% from price
SMA 200
1.08
+473.38% from price
EMA 12
4.83
+26.79% from price
EMA 26
3.87
+58.00% from price
EMA 50
2.86
+113.70% from price
RSI (14)
58.1
Neutral
MACD (12,26,9)
0.95
Hist 0.11
ATR (14)
1.35
21.72% of price
Realised vol 30D
2780.5%
Annualised
Bollinger upper
8.64
20, 2σ
Bollinger lower
-1.59
20, 2σ
50 / 200 cross
Golden
2.29 vs 1.08
Trend bias
Above 200
+473.38%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
7.23
More volatile than market
Correlation to SPY
0.01
Largely independent
Realised vol 30D
2780.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-99.4%
Peak to trough
Max drawdown 5Y
-99.5%
Peak to trough
ATR 14
1.35
21.72% of price
Beta (reported)
—
5Y monthly, from filing
Short interest
Shares short
2.74K
Prior 12.52K
Change vs prior
-78.1%
Shorts covering
% of float
0.48%
Normal
% of shares out
0.36%
Against total outstanding
Days to cover
0.0
Liquid
Float
477.67K
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:75
Split dateAug 7, 2026
SEC filings
Periodic Financial Reports
10-Q · 2026-08-14
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-07-28
Corporate Changes & Voting Matters
8-K · 2026-07-21
Corporate Changes & Voting Matters
8-K · 2026-06-30
Offering Registrations
S-1 · 2026-06-26
Proxy Statements
PRE 14A · 2026-06-09
Corporate Changes & Voting Matters
8-K · 2026-05-21
Headlines
US Equity Indexes Rise Despite Surging Bond Yields as US Nears Tariff Deal With Canada
MT Newswires · 2d ago
Sector Update: Healthcare Stocks Advance Late Afternoon
MT Newswires · 2d ago
US Equity Indexes Rise Despite Surging Bond Yields
MT Newswires · 2d ago
Jupiter Neurosciences Prices $2.0 Million Direct Offering
MT Newswires · 2d ago
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
GlobeNewswire · 2d ago
Real Parkinson’s Disease Hope from Jupiter Neurosciences
Exec Edge · 4d ago
Jupiter Neurosciences, Inc. Announces Reverse Stock Split
GlobeNewswire · 18d ago
Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva
IPO-Edge.com · 32d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.